Profile

Ritu Pandey

Associate Director, Translational Clinical Bioinformatics | Associate Research Professor, Cellular and Molecular Medicine - (Research Series Track) | Coordinator, Biomedical Informatics | Member of the Graduate Faculty

AZ Health Sci Ctrs & Divisions

Full Page

Overview

Research

Collaboration(51)

Page 1 of 11

Grants(8)

The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT)
Active·2024·$284.5K / $2.8M·
External
Co-Investigator (COI)
biorepository, pituitary, neuroendocrine, tumor, translational research
Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease.
Active·2023·$186.4K / $847.5K·
External
Co-Investigator (COI)
organoid model, pituitary adenoma, cushing's disease, development, standardization
University of Arizona Cancer Center - Cancer Center Support Grant
Active·2022·$0 / $12.6M·
External
cancer research, medical oncology, grants, cancer treatment, supportive care
Functional and Structural Diversity in Hypoglossal Motoneurons
Active·2022·$133.3K / $888.9K·
External
Co-Investigator (COI)
neural diversity, motor control, neuroscience, neural circuitry, cell biology
Abdominal Adiposity in Early-Onset and Aggressive Clear Cell Renal Cell Carcinoma and Health Disparities
Active·2021·$86.5K / $865.5K·
External
Co-Investigator (COI)
cancer, obesity, health disparities, renal cell carcinoma, adiposity

Page 1 of 2

Publications(12)

Recent

Development Of Human Pituitary Adenoma-Derived Organoids To Facilitate Effective Targeted Treatments Of Cushing's Disease.

2022

organoids, cushing's disease, targeted treatments, pituitary adenoma, development

Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival

2022

cancer, biomarkers, prognosis, gene expression, tumor aggressiveness

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

2021

non-coding rna, tumor plasticity, neuroendocrine prostate cancer, regulation, tumor

Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer

2021

molecular pathways, kallikrein 6, colorectal cancer, overexpression, molecular research

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours

2021

genomics, cancer, transcription, neuroendocrine, tumours

A Comparative Analysis of Tumor and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients annotated by 3 Core Cellular Processes

2020

cancer genetics, liquid biopsy, tumor dna analysis, cellular processes, clinical oncology

TP53 mutations as a driver of metastasis signaling in advanced cancer patients

2020

cancer, metastasis, tp53 mutations, driver, signaling

Carcinoembryonic antigen cell adhesion molecule 6 CEACAM6) in Pancreatic Ductal Adenocarcinoma PDA) An integrative analysis of a novel therapeutic target

2019

cancer, pancreatic cancer, therapeutic targets, cell adhesion molecules, integrative analysis

Targeting the PIM Protein Kinases for the Treatment of a T-cell Acute Lymphoblastic Leukemia Subset

2017

proteins, cancer, treatment, leukemia, kinases

Specific microRNA-mRNA regulatory network of colon cancer invasion regulated by tissue kallikrein-related peptidase 6

2017

microrna, mrna, colon cancer, regulatory network, tissue kallikrein-related peptidase 6

People

Profile

Ritu Pandey

Collaboration(51)

H-H. Sherry Chow

Cynthia Thomson

Denise Roe

Bonnie LaFleur

David Besselsen

Grants(8)

The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT)

Development and Standardization of a Novel Pituitary Adenoma Organoid Model for the Study and Treatment of Cushing's Disease.

University of Arizona Cancer Center - Cancer Center Support Grant

Functional and Structural Diversity in Hypoglossal Motoneurons

Abdominal Adiposity in Early-Onset and Aggressive Clear Cell Renal Cell Carcinoma and Health Disparities

Publications(12)

Development Of Human Pituitary Adenoma-Derived Organoids To Facilitate Effective Targeted Treatments Of Cushing's Disease.

Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival

The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer

Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours

A Comparative Analysis of Tumor and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients annotated by 3 Core Cellular Processes

TP53 mutations as a driver of metastasis signaling in advanced cancer patients

Carcinoembryonic antigen cell adhesion molecule 6 CEACAM6) in Pancreatic Ductal Adenocarcinoma PDA) An integrative analysis of a novel therapeutic target

Targeting the PIM Protein Kinases for the Treatment of a T-cell Acute Lymphoblastic Leukemia Subset

Specific microRNA-mRNA regulatory network of colon cancer invasion regulated by tissue kallikrein-related peptidase 6